Lubiprostone Capsule, Gelatin Coated
Product Images NDC 63304-352

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 63304-352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp 24 (24pdp)

Reony Lubiprostone is a medication in the form of capsules. Each capsule contains 24 mcg of lubiprostone. It is distributed by Sun Pharmaceutical Industries Inc. in Cranbury, NJ. The active ingredient is made in Japan and encapsulated in the United States. The package insert contains complete prescribing information. It is important to keep the medication out of reach of children and dispense it in a tightly closed, light-resistant container. Swallow the capsule whole and do not break it apart or chew. Not available information is written in the text.*

FDA Label Image

Pdp 8 Mcg (8pdp)

This is a description for a medication capsule. The medication is called lubiprostone and each soft gel capsule contains 8 mcg of it. It is distributed by Sun Pharmaceutical Industries and comes in a container that must be kept out of reach of children. The capsule should be swallowed whole and not be broken apart or chewed. The package insert contains complete prescribing information. The expiration date is May 2022.*

FDA Label Image

Chemical Structure (Amitiza 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.